Loading company…
Tongshu Gene provides tumor genetic testing, diagnostic services, and related health management tools.
Founded in 2016 and based in Shanghai, China, Tongshu Gene provides tumor testing for medication selection, treatment monitoring, recurrence monitoring, and risk prediction. Its products include ctDNA testing tools, an MSI detection kit, and an online oncology hospital offering video consultations. It raised over CNY 100 million in Series D funding in October 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in